In a six-months study, with the dosage of 2.5 mg tablets three times per day plus bronchodilators as a basic treatment in elderly patients with COPD, patients had better FEV1, TNFα and c-reactive protein blood and interleukin 6 level in comparison to the placebo group [60]. Here, TNF is linked to chronic obstructive pulmonary disease.